Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase

NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (NASDAQ:PBM) ("Psyence Biomed" or the "Company") today announced that management will host 1x1 meetings with investors during the A.G.P. Virtual

GlobeNewswireMay 17 07:00 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersArcutis Biotherapeutics (NASDAQ:ARQT) stock moved upwards by 16.4% to $9.46 during Tuesday's after-market session. The company's market cap stands at $1.0 billion. As per the press release, Q1

BenzingaMay 14 16:31 ET

CRVS, CTMX and NRXP Are Among Premarket Gainers

Seeking AlphaMay 6 08:39 ET

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersCytomX Therapeutics (NASDAQ:CTMX) stock increased by 154.6% to $4.15 during Wednesday's regular session. The market value of their outstanding shares is at $281.0 million. Cyclacel Pharmaceutic

BenzingaMay 1 12:31 ET

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More

Welcome to Benzinga's psychedelic headlines roundup. This is our pick of must-read news items from the first two weeks of April 2024.See previous edition Psychedelics Headlines: A Form Of Life, Treati

BenzingaApr 17 09:13 ET

Express News | Psyence Biomedical Ltd: Anticipates Enrolling First Subject in Q2 of 2024 and Expects Primary Endpoint Results to Be Available in 2025

Moomoo 24/7Apr 17 08:06 ET